Pages that link to "Q35661987"
Jump to navigation
Jump to search
The following pages link to Molecular insights into regulation of JAK2 in myeloproliferative neoplasms (Q35661987):
Displaying 21 items.
- Pathogenesis of myeloproliferative neoplasms (Q26799656) (← links)
- Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation (Q29147543) (← links)
- The evolving world of pseudoenzymes: proteins, prejudice and zombies (Q34544475) (← links)
- New Strategies in Myeloproliferative Neoplasms: The Evolving Genetic and Therapeutic Landscape (Q36782943) (← links)
- Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms (Q37555785) (← links)
- Gene expression profiling of acute type A aortic dissection combined with in vitroassessment†. (Q38434891) (← links)
- Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations (Q38586919) (← links)
- O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies (Q39028183) (← links)
- How Does the L884P Mutation Confer Resistance to Type-II Inhibitors of JAK2 Kinase: A Comprehensive Molecular Modeling Study. (Q41490661) (← links)
- What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer? (Q47694495) (← links)
- Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase (Q49367076) (← links)
- Myeloproliferative neoplasms: from origins to outcomes. (Q49989025) (← links)
- Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling (Q51284981) (← links)
- Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway. (Q55042835) (← links)
- Cytokine Receptors (Q57252653) (← links)
- Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain (Q60047595) (← links)
- MLL-PTD in a 13-year-old patient with blast phase myeloproliferative neoplasm: A case report (Q60054198) (← links)
- BCR: a promiscuous fusion partner in hematopoietic disorders (Q64120437) (← links)
- Molecular analysis of V617F mutation in Janus kinase 2 gene of breast cancer patients (Q90086950) (← links)
- Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from Pakistan (Q90290740) (← links)
- Janus kinases to jakinibs: from basic insights to clinical practice (Q91925305) (← links)